Be part of the only conference that presents strategies and solutions for every link of the controlled substances supply chain.
Connect with government officials and key industry stakeholders from throughout the controlled substances supply chain to examine the latest legal and regulatory developments impacting the industry. Attend and learn how to best conform business practices to meet industry and regulatory demands, bolster compliance programs, mitigate risk, and reduce liability.
HEAR FROM OUR 2023 CO-CHAIRS
Conference Co-Chairs
Gustav Eyler
Partner
Gibson, Dunn, & Crutcher LLP
Former Director of Consumer Protection Branch, U.S. Department of Justice
Jolie Apicella
Partner
Wiggin & Dana LLP
Former AUSA, Chief of Healthcare Fraud, Eastern District of New York
Cori Rizman
Director, Compliance – Controlled Substances Oversight Region North America
Fresenius-Kabi USA
Former Diversion Group Supervisor, DEA
Government Keynotes
Dominic Chiapperino, Ph.D.
Director, Controlled Substance Staff
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Amanda Liskamm
Director, Consumer Protection Branchh
U.S. Department of Justice
Government Speakers
Matthew Feeley
Deputy Chief & Healthcare Fraud Coordinator, USAO SDFL Civil Division
U.S. Department of Justice
Monica Hanna
Special Counsel
Office of the NY State Attorney General
Justin G. Wood
Diversion Program Manager, Washington Division
Drug Enforcement Administration
Gabriel H. Scannapieco
Assistant Director, Consumer Protection Branch
United States Department of Justice
Jonathan Lenzner
Chief of Staff
Federal Bureau of Investigations
Natalie Waites
Assistant Director, Fraud Section, Civil Division
U.S. Department of Justice
Francis Godwin
Director, Office of Manufacturing Quality
U.S. Food and Drug Administration
Scott B. Dahlquist
Opioid Coordinator, Consumer Protection Branch
U.S. Department of Justice
Arun Rao
Deputy Assistant Attorney General
U.S. Department of Justice, Civil Division
Anthony J. Nardozz
Assistant Director
U.S. Department of Justice, Consumer Protection Branch, Civil Division
Lisa Miller
Deputy Assistant Attorney General, Fraud and Appellate Sections
U.S. Department of Justice, Criminal Division
Industry Thought Leaders Will Help You
- ASSESS the current status of the National Opioid Litigation and MDL Settlements
- ANALYZE the therapeutic potential of marijuana and psychedelics
- EVALUATE the role of Telemedicine in controlled substances prescribing, distribution, and abuse
- DEVELOP a comprehensive Controlled Substances Compliance Program
- RESPOND effectively to DEA and FDA investigations
Here’s what some of our attendees had to say
This conference was spot on with the issues we are facing everyday.
It was great to hear from current and former industry leaders and experts from DEA, US AG offices, FDA, etc. Hearing about the current events and upcoming trends/expectations was valuable.
As the Director of Compliance for IPC, I was extremely pleased with last year’s speakers and the insight they provided into the latest controlled substance regulations.
View our return to in-person All Secure safety plan.
Concerned About Traveling?
Check out our WORRY-FREE GUARANTEE
Register at the preferred early rate with our worry free cancellation guarantee.
Learn More
Livestream Also Available
Join a real-time interactive broadcast of the in-person conference virtually from your location.
Learn MoreRelated Conferences
